BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 16, 2009
 |  BC Week In Review  |  Company News  |  Deals

Synosia, Roche deal

The companies added Roche's SYN120 to a 2007 deal that granted Synosia (formerly Synosis Therapeutics Inc.) exclusive, worldwide rights to develop and commercialize five oral small molecules from the pharma for neurological and...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >